- Home
- WTBA vs CTNM Comparison
WTBA vs CTNM Comparison
Compare WTBA & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | WTBA | CTNM |
|---|---|---|
| Founded | 1893 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.9M | 416.1M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | WTBA | CTNM |
|---|---|---|
| Price | $22.19 | $11.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $23.50 | $18.60 |
| AVG Volume (30 Days) | 29.6K | ★ 234.6K |
| Earning Date | 01-29-2026 | 03-05-2026 |
| Dividend Yield | ★ 4.48% | N/A |
| EPS Growth | ★ 49.53 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $91,783,000.00 | N/A |
| Revenue This Year | $27.90 | N/A |
| Revenue Next Year | $13.86 | N/A |
| P/E Ratio | $11.76 | ★ N/A |
| Revenue Growth | ★ 19.66 | N/A |
| 52 Week Low | $17.31 | $3.35 |
| 52 Week High | $24.27 | $13.49 |
Technical Indicators
Market Signals| Indicator | WTBA | CTNM |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 55.75 |
| Support Level | $21.92 | $8.92 |
| Resistance Level | $22.55 | $12.29 |
| Average True Range (ATR) | 0.48 | 0.93 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 40.28 | 73.76 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.